Top Glaucoma Surgery Devices Companies

Glaucoma Surgery Devices Market size was valued at USD 1.54 Billion in 2024 and is poised to grow from USD 1.61 Billion in 2025 to USD 2.33 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026–2033).

Developing glaucoma surgery devices that are affordable should be the prime focus of glaucoma surgery device providers in the future. Collaborations and acquisitions are also expected to emerge as key opportunities for glaucoma surgery device companies going forward. Entering emerging markets is also expected to present new opportunities for glaucoma surgery device suppliers.   'Alcon Inc. (Switzerland)', 'Glaukos Corporation (US) ', 'Johnson & Johnson Vision (US) ', 'ASICO, LLC (US) ', 'Carl Zeiss Meditec AG (Germany) ', 'Ziemer Ophthalmic Systems AG (Switzerland) ', 'Iridex Corporation (US) ', 'Altomed (UK) ', 'New World Medical, Inc. (US) ', 'Ellex Medical Lasers Ltd. (Australia) ', 'Topcon Corporation (Japan) ', 'BVI Medical, Inc. (US) ', 'MicroSurgical Technology (MST) (US) ', 'Molteno Ophthalmic Ltd. (New Zealand) ', 'OptoMedica Corporation (US) ', 'iStar Medical SA (Belgium) ', 'NeoMedix Corporation (US) ', 'Sight Sciences, Inc. (US) ', 'Aquesys, Inc. (US) ', 'IOP Ophthalmics (US) ', 'Katena Products, Inc. (US)'

Minimally Invasive Glaucoma Surgery: Glaucoma surgery device companies should focus on developing and launching new devices capable of performing minimally invasive surgeries. Growing preference for minimally invasive surgeries among people owing to faster recovery times and less hospitalization is projected to make this a key glaucoma surgery devices market trend in the long run.   

North America is predicted to spearhead the demand for glaucoma surgery devices in the world. The presence of a massive geriatric population, high incidence of diabetes, and poor lifestyles of people in this region are aiding the high share of North America. Moreover, high healthcare expenditure coupled with quick adoption of minimally invasive glaucoma surgeries are also slated to create new opportunities for glaucoma surgery device providers in this region. The United States and Canada are estimated to emerge as the most opportune markets in the North American region in the future.